Maternal and Zygotic aldh1a2 Activity Is Required for Pancreas Development in Zebrafish by Alexa, Kristen et al.
Maternal and Zygotic aldh1a2 Activity Is Required for
Pancreas Development in Zebrafish
Kristen Alexa, Seong-Kyu Choe, Nicolas Hirsch
¤, Letitiah Etheridge, Elizabeth Laver, Charles G.
Sagerstro ¨m*
Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America
Abstract
We have isolated and characterized a novel zebrafish pancreas mutant. Mutant embryos lack expression of isl1 and sst in the
endocrine pancreas, but retain isl1 expression in the CNS. Non-endocrine endodermal gene expression is less affected in the
mutant, with varying degrees of residual expression observed for pdx1, carbA, hhex, prox1, sid4, transferrin and ifabp.I n
addition, mutant embryos display a swollen pericardium and lack fin buds. Genetic mapping revealed a mutation resulting
in a glycine to arginine change in the catalytic domain of the aldh1a2 gene, which is required for the production of retinoic
acid from vitamin A. Comparison of our mutant (aldh1a2
um22)t oneckless (aldh1a2
i26), a previously identified aldh1a2
mutant, revealed similarities in residual endodermal gene expression. In contrast, treatment with DEAB (diethylamino-
benzaldehyde), a competitive reversible inhibitor of Aldh enzymes, produces a more severe phenotype with complete loss
of endodermal gene expression, indicating that a source of Aldh activity persists in both mutants. We find that mRNA from
the aldh1a2
um22 mutant allele is inactive, indicating that it represents a null allele. Instead, the residual Aldh activity is likely
due to maternal aldh1a2, since we find that translation-blocking, but not splice-blocking, aldh1a2 morpholinos produce a
phenotype similar to DEAB treatment. We conclude that Aldh1a2 is the primary Aldh acting during pancreas development
and that maternal Aldh1a2 activity persists in aldh1a2
um22 and aldh1a2
i26 mutant embryos.
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Introduction
Similar to the pancreas of other vertebrates, the zebrafish
pancreas consists of an endocrine and an exocrine portion. The
zebrafish exocrine pancreas consists of acinar cells that release
digestive enzymes into the intestine and the endocrine pancreas is
composed of five cell types that secrete hormones directly into the
blood stream; insulin producing b-cells, somatostatin producing d-
cells, glucagon producing a-cells, pancreatic polypeptide hormone
secreting PP-cells and ghrelin producing e-cells [1,2]. The
zebrafish pancreas develops from a dorsal and a ventral bud
associated with the gut tube, where the dorsal bud is located
slightly posterior to the ventral bud [3,4]. The dorsal bud is the
first to form at 24 hpf and eventually gives rise to endocrine
pancreas. By 40 hpf, the ventral bud has formed and is composed
of exocrine cells as well as a few endocrine cells. By 52 hpf, the two
buds have merged to form one organ on the right side of the
embryo, consisting of a single islet of endocrine cells surrounded
by the exocrine pancreas [3,4].
As in other vertebrates, expression of pdx1 marks the future
position of the pancreas in zebrafish embryos [2,5,6]. Zebrafish
pdx1 expression is first observed at 14 hpf [7,8]; but cell
transplantations have demonstrated endoderm commitment as
early as 5 hpf [9]. At this early point, endoderm cells express sox17,
a gene necessary for endoderm development [9,10,11]. Various
intercellular signaling molecules act on these early endodermal
cells to direct their differentiation into organs such as the pancreas.
These factors include sonic hedgehog (Shh), bone morphogenetic
protein (Bmp), transforming growth factor b (TGF-b), fibroblast
growth factor (Fgf) and retinoic acid (RA) [6,7,12,13,14,15,16].
RA is involved in the formation of the central nervous system,
lung, kidney, intestine, and pancreas [12,15,17,18,19,20]. In
particular, RA is needed at the end of gastrulation for pancreas
development and blocking RA signaling in zebrafish embryos
prevents pancreas formation [15]. Accordingly, exogenously
applied RA induces ectopic pancreatic gene expression in the
anterior endoderm [15]. Experiments in amphibian and avian
models give similar results, indicating a vertebrate requirement for
RA in pancreas development [7,12,13]. RA is a small lipophilic
molecule derived from dietary vitamin A (retinol). Retinol is
converted to an aldehyde (retinaldehyde) which is further
converted to a carboxylic acid (retinoic acid). The first step,
oxidation of retinol to retinaldehyde, is made possible by several
retinol dehydrogenases (RDHs) that have widespread and
overlapping expression patterns. The second step, oxidation of
retinaldehyde to RA, is carried out by retinaldehyde dehydroge-
nases (Raldh or Aldh), which have more tissue specific expression
patterns [21,22,23,24,25]. In particular, aldh1a2 (raldh2) is the
major retinoic acid generating enzyme in the early mouse embryo
and was thought until recently to be the only raldh expressed in
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identified in zebrafish [26,27] but aldh1a1 (raldh1) has not been
found in zebrafish to date. aldh1a3 is expressed in the developing
eye and ear after gastrulation and aldh8a1 is expressed later around
2 dpf in the liver and intestine [26,27] suggesting that these genes
are not involved in early pancreas development. In contrast,
aldh1a2 is expressed at 30% epiboly in the mesendoderm and
continues to be expressed in the posterior and lateral mesoderm
during segmentation [28]. At later stages, aldh1a2 is expressed in
the somites and the pronephric anlage (by 15 hpf) as well as in
pharyngeal arch and pectoral fin mesenchyme (32 hpf)
[28,29,30,31,32,33]. Expression of aldh1a2 adjacent to, but not
within, the pancreatic anlage is consistent with observations that
the anterior paraxial mesoderm is a source of RA driving pancreas
formation. Accordingly, three Retinoic Acid Receptors (two
RARa and one RARc) are expressed in the endoderm, indicating
that the RA signal can be received directly in the endoderm [8].
We carried out a haploid ENU (N-ethyl-N-nitrosourea) screen
for endocrine pancreas mutations and discovered a mutant (88.21)
that does not develop isl1 expression in the endocrine pancreas,
but maintains isl1 expression in the CNS. More detailed analysis of
the 88.21 mutant revealed residual expression of several pancreas
(e.g. pdx1) and liver (e.g. hhex and prox1) genes, suggesting that
endoderm organ differentiation, including pancreas formation, is
not completely lost in the mutant. We mapped the 88.21 mutant
using a CA panel and identified a mutation in the catalytic domain
of the aldh1a2 gene; therefore we named our mutant aldh1a2
um22.
Two other mutant alleles for aldh1a2 have been reported, neckless
(nls or aldh1a2
i26/i26; a point mutation in the NAD binding domain)
and no fin (nof or aldh1a2
u11/u11; a point mutation in the catalytic
domain) [28,34]. A detailed analysis of endoderm gene expression
in aldh1a2
i26 embryos revealed residual expression of several
endoderm markers, (e.g. pdx1), similar to the phenotype seen in
aldh1a2
um22 mutants. In contrast, we find that embryos treated with
DEAB (diethylaminobenzaldehyde), a competitive reversible
inhibitor of all Aldhs, completely lack expression of all pancreas
and liver genes, indicating that there is residual Aldh activity in
aldh1a2
um22 and aldh1a2
i26 mutant embryos. Notably, targeting
both maternal and zygotic transcripts using MOs to the aldh1a2
translation start site produces a phenotype comparable to DEAB
treatment. In contrast, targeting primarily zygotic transcripts using
MOs to the exon1/intron1 splice site of aldh1a2 does not fully
block endodermal gene expression. Our results reveal an absolute
requirement for Aldh activity in pancreas development and
demonstrate residual Aldh activity in aldh1a2
um22 and aldh1a2
i26
mutants, likely due to maternally contributed Aldh1a2.
Materials and Methods
Fish Maintenance
Ekkwill (EK), Tupfel long fin (TL) and neckless (aldh1a2
i26) (Gift
from Prince Lab) embryos were collected from natural matings
and reared in 1/3 Ringer’s. Embryos were staged using
morphological criteria up to 24 hours post fertilization (hpf) and
then by time of development at 28.5uC [35].
ENU Screen
EK males were treated with 3 mM ENU (N-ethyl-N-nitroso-
urea) once a week for 3 weeks. The males were then crossed
repeatedly to clean out any post meiotic germ cells that were
mutagenized. Mutagenized males were then crossed to EK females
and the progeny (F1) were raised. Haploid embryos were
produced by In Vitro Fertilization (IVF) of F1 female progeny
with irradiated sperm. Haploid embryos were raised to approx-
imately 30 hpf and fixed in 4% paraformaldehyde for in situ
hybridization with islet1 (isl1) probe. Embryos were screened based
on isl1 expression. F1 females that produced embryos with mutant
phenotypes were out-crossed to TL males and the progeny (F2)
were raised and in-crossed for recovery of mutation in diploid
embryos.
Mapping, DNA Extraction, RNA Extraction and cDNA
Synthesis
Mutant carriers were in-crossed and progeny raised to 4 dpf.
Embryos were sorted based on their phenotype; mutants develop a
swollen pericardium and lack fin buds. Genomic DNA was
extracted from phenotypically mutant and phenotypically wild type
embryos at day 4. DNA pools were created from phenotypically
mutant and wild type embryos. Bulk segregant analysis was
performed on the DNA pools using a 192 CA marker panel
[36,37,38]. Two markers were found to be linked to the mutation:
z10441 (FW:GCATTCAGATTCTGGGGTGT, RV: CGGAT-
GAACCCATCAATCTC) and z8693 (FW: GCTTTTTGAGCA-
GATGAGGC, RV: CATGTACGCGTTGACTTTGC). PCR
was performed on individual embryos using the same primers.
cDNA was synthesized from RNA extracted from pools of 10
phenotypically mutant and 10 phenotypically wild type embryos
using Invitrogen Superscript III Reverse Transcriptase Kit. PCR
primers, FW: CCAAAGTTGTAATCGCACATC, RV:TTTT-
TTTTTTTTTTTCAGAGGTAAAAC, were used to clone full-
length aldh1a2 cDNA. Stratagene Hi Fi taq polymerase was used in
the PCR and the product was sequenced. Primers FW:
AGCGGCCGTCTTCCCAGAGATATC and RV: GGAATG-
GGTGTAGGCAGTTAATGGTGG were used to sequence
aldh1a2 from individual embryos.
mRNA and Morpholino Injections
An antisense morpholino oligo (MO) designed to block
translation of the aldh1a2 mRNA (tMO) 59GCAGTTCAACTT-
CACTGGAGGTCAT39 [28] and one control mismatch morpho-
lino (mmMO 59GCAcTTgAACTTCAgTGGAcGTgAT39 that
has five mismatches relative to tMO) were obtained from Gene
Tools. 1 nl of 100 uM, 250 uM, 500 uM, 750 uM and 950 uM of
tMOwasinjectedatthe1–2 cell stage.A spliceMO(sMO)designed
to exon1/intron1 splice junctions: 59TTGAAAAAGTCCGA-
CAAACCTTGGT39 and one control morpholino (mmMO:
59TTcAAAAAcTCgGACAAtCCTTcGT39 with five mismatches
relative to sMO) was obtained from Gene tools. 1 nl of 500 uM,
750 uM, and 950 uM of sMO was injected at the 1–2 cell stage.
For rescue experiments, the aldh1a2 ORF was amplified from
TL embryos or aldh1a2
um22 mutant embryos using FW: AT-
GACCTCCAGTGAAGTTGAACTGCCA and RV:TTAAGA-
CGTCTTGCTTCATCGTAATGGTTTTCA. Both ORFs were
cloned with Invitrogen Topo TA Cloning kit, digested using
EcoR1 and cloned into PCS2+. Constructs were linearized with
Not1 and Ambion Kit Sp6 was used to make mRNA. 500 pg
of mRNA was injected into an aldh1a2
um22 in-cross at 1–2 cell
stage. mRNA and MO injected embryos were fixed in 4%
paraformaldehyde at various developmental stages for in situ
hybridization.
DEAB Treatment
A 1 mM stock of DEAB was dissolved in DMSO. Embryos
were treated in the dark with 1 uM, 5 uM and 10 uM of DEAB
dissolved in 1X PTU at 6, 8, 10, or 12 hpf. Embryos were fixed at
various stages and assayed by in situ hybridization. Control
embryos were treated in DMSO under similar conditions.
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Antisense digoxigenin- and fluorescein-labeled probes were
produced by standard methods. The krx20, myosin heavy chain (mhc),
insulin, sid4, carbA, pdx1, isl1, transferrin, p48, somatostatin, ifabp
(intestinal fatty acid binding protein) and shh probes used were described
previously [39,40,41]. Full-length prox1 was obtained from Open
Biosystems, One- and two-color in situ hybridization was carried
out as described previously [39,40].
RT-PCR
RT-PCR was performed using a Qiagen PCR Kit (Cat. No
204054) and cDNA synthesized from wild type embryos at 3 and
6 hpf. RNA was extracted from 10 wild type embryos at 3 hpf or
6 hpf and cDNA was synthesized using Invitrogen Superscript III
Reverse Transcriptase Kit. The following primers were used to
obtain PCR product: BActin FW: ATACACAGCCATGGAT-
GAGGAATTCC and RV: GGTCGTCCAACAATGGAGGG-
GAAAA, Tubulin 1 FW: AAGAGATGACGCAGTCTGTCG-
TAGTC and RV: AGAAGCTCGTCAGCGCGTCATCATAA,
Odc-1 FW: TTTGACTTCGCCTTCCTGGAGGAGGGand RV:
CCCCAGATCCGCCACATAGAAGGCAT,a l d h 1 a 2
1-2 FW: AT-
GACCTCCAGTGAAGTTGAACTGC and RV: CTTGTCG-
GATTCCTGGACATCACAG, and aldh1a2
10-11 FW: GCAAAG-
CTCCTCCTACTAAAGGCTTCTTC and RV: TTCTGTGT-
TGTTGGCTCTCTCAATCACT.
Results
An ENU Screen for Zebrafish Pancreas Mutants
A haploid in situ hybridization screen of ENU (N-ethyl-N-
nitrosourea) mutagenized zebrafish was carried out to identify
mutations in endocrine pancreas development. Ekkwill (EK) males
were treated with 3 mM ENU and crossed to EK females. F1
progeny was raised and eggs from F1 females were in vitro
fertilized using irradiated sperm from EK males. The resulting
haploid embryos were raised until 30 hpf and assayed by in situ
hybridization for islet1 (isl1) expression to detect defects in the
endocrine pancreas. F1 females that produced clutches with 50%
mutant embryos were outcrossed to Tupfel long fin (TL) males. F2
progeny were raised and screened for recovery of the mutation in
the F3 generation. We screened 200 genomes and discovered ten
females with defective endocrine pancreas formation. Six of the
ten females died, developed tumors or did not produce progeny.
Out of the remaining four females, we recovered diploid mutants
for two.
Embryos from one of the recovered mutants (88.21) lack isl1
expression in the endocrine pancreas, but maintain expression in
the CNS (Figure 1B versus wild type in Figure 1A). 88.21 embryos
first display a morphological phenotype approximately at day 4, as
they do not develop fin buds and have a swollen pericardium
(Figure 1D versus wildype in Figure 1C). Since the EK and TL
strains used in our screen are highly polymorphic with respect to
their CA repeats, we used a PCR panel consisting of 192 primer
pairs that amplify CA repeats in the zebrafish genome to map the
position of the mutation [36,37,38]. Specifically, genomic DNA
pools from phenotypically wild type and phenotypically mutant
embryos were amplified using primers from the CA marker panel.
Based on the bulk segregant analysis of the DNA pools, two
markers, z10441 and z8693, were found to be linked to the
mutation (Figure 1F). Subsequent PCR of inividual embryos (not
shown) confirmed the linkage. We detected three crossovers out of
44 meioses for the z10441 marker, which places the mutation
approximately 7 cM away from this marker on linkage group 7
(Figure 1G).
The 88.21 Mutant Represents a Novel aldh1a2 Allele
A closer examination revealed that the z10441 and z8693
markers are both located near the aldh1a2 (raldh2) gene on
chromosome 7. As noted, aldh1a2 is a retinaldehyde dehydrogenase
(Raldh) involved in RA synthesis and there are two previously
reported aldh1a2 mutants, neckless (nls or aldh1a2
i26; Figure 1E) and
no fin (nof or aldh1a2
u11) [28,34]. Since the 88.21 mutant phenotype
bears some resemblance to the aldh1a2
i26 phenotype (Figure
1D, E) – lack of pectoral fins, swollen pericardium and embryonic
lethality by day 6 - we tested if 88.21 might represent a novel
aldh1a2 allele. To this end, we amplified full length aldh1a2 from
cDNA prepared from mutant and wild type embryo pools derived
from an 88.21 incross. Sequencing of the PCR products identified
a G to A change in the mutant pool that converts a glycine to an
arginine at position 484 (Figure 1H, J) in the catalytic domain of
Aldh1a2 (Figure 1K). Sequencing cDNA from individual embryos
confirmed this change (Figure 1I).
To confirm that the 88.21 phenotype is caused by a mutation in
the aldh1a2 gene, we set out to rescue the mutant phenotype with
wild type aldh1a2 mRNA. We find that 26% of embryos from an
incross of 88.21 heterozygotes fail to develop fin buds (Table 1), as
assayed by shh expression in fin buds at 48 hpf (Figure 2A, B) or by
visual inspection for fin bud formation at 72 hpf (not shown).
However, following injection of wild type aldh1a2 mRNA at the 1–
2 cell stage, only 8.5% of embryos lack fin buds, demonstrating
that aldh1a2 mRNA rescues fin bud development (Table 1,
Fig. 2C). In contrast, injection of aldh1a2 mRNA containing the
88.21 mutation does not rescue fin bud development (24% lack fin
buds; Table 1, Fig. 2D). Notably, the swollen pericardium
phenotype was not rescued by injection of aldh1a2 mRNA. This
result is consistent with previous work showing that fin bud
development in aldh1a2
i26 and aldh1a2
u11 can be rescued by
injecting wild type aldh1a2 mRNA, but the swollen pericardium
cannot be rescued [28,34]. We conclude that the 88.21 mutation
occurs in the aldh1a2 catalytic domain and we refer to it as
aldh1a2
um22. Since the mutant mRNA appears to be inactive even
when overexpressed, the aldh1a2
um22 allele is likely to represent a
null allele. In particular, replacing a small conserved glycine
residue with a large arginine in the catalytic domain may affect the
function or folding of the Aldh1a2 protein.
Endoderm Gene Expression Is Variably Affected in
aldh1a2
um22 and aldh1a2
i26 Mutants
We observe variable effects on endoderm gene expression in
aldh1a2
um22 mutants and we therefore compared the aldh1a2
um22
phenotype to the aldh1a2
i26 phenotype. The aldh1a2
i26 allele was
previously analyzed with some endodermal markers [15] but we
have expanded the analysis further. We find that endocrine-
specific genes such as isl1 (Table 2) and sst1 (Table 2) are
completely lost in both mutants at 24–30 hpf, as is p48 expression
in the exocrine pancreas (Table 2). In contrast, pdx1 expression
remains in the majority of both aldh1a2
i26 and aldh1a2
um22 mutant
embryos (Figure 3E versus 3G, H; Figure 4A versus 4C, D;
Table 2), as does carboxypeptidase A (carbA) expression, although
carbA expression is more pronounced in aldh1a2
i26 (Figure 4I versus
4K, L; Table 2). We also find that expression of hhex and prox1
(that are expressed in both the ventral pancreatic bud and the
liver) persists in both mutants (Figure 3I versus 3K, L and 3M
versus 3O, P; Table 2). Analyzing other liver markers later in
development revealed that expression of both sid4 (at 48 hpf) and
transferrin (transf, at 72 hpf) persists in both aldh1a2
um22 and
aldh1a2
i26 mutant embryos (Figure 4E versus 4G, H; 4Q versus
4S, T; Table 2). intestinal fatty acid binding protein (ifabp) expression is
decreased at 72 hpf (Figure 4M versus 4O, P; Table 2) in
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PLoS ONE | www.plosone.org 3 December 2009 | Volume 4 | Issue 12 | e8261Figure 1. 88.21 is a novel aldh1a2 allele. A, B. Islet1 (isl1) expression was used in a haploid ENU screen to identify mutants in endocrine pancreas
development. Dorsal view of 30 hpf wild type embryo with isl1 expression in the CNS and endocrine pancreas (A; black arrow indicates expression in
pancreas) and 88.21 mutant embryo with isl1 expression in the CNS, but not in the endoderm (B). C–E. Lateral view of live wild type (C), 88.21 (D), and
neckless aldh1a2
i26 (E) embryos at day 5. F. Linkage analysis using CA repeat markers on pooled genomic DNA from 88.21 mutants and pooled
genomic wild type DNA. Marker z10441 amplifies a 450 bp band and a faint 500 bp band in the mutant pool compared to a faint 450 bp band and a
500 bp band in the wild type pool. Marker z8693 amplifies two bands at 250 bp and 300 bp in the mutant pool compared to 250 bp, 300 bp as well
as a 400 bp band in the wild type pool. White arrow points to lack of 400 bp band in mutant. G. Schematic drawing of part of linkage group 7 (LG7),
showing the location of z10441 and z8693 and aldh1a2 (in red) in reference to these markers. H–J. Sequence analysis of pooled 88.21 mutant (MT)
genomic DNA and pooled wild type (WT) genomic DNA (H, J), as well as of individual mutant (MT) and wild type (WT) embryos (I). 88.21 fish carry a
mutation that converts Gly
484 to Arg (in red, and outlined in brackets in J) located in the catalytic domain. K. Schematic of Aldh1a2 protein and the
location of the aldh1a2 mutant alleles aldh1a2
i26, aldh1a2
u11 and 88.21/aldh1a2
um22.
doi:10.1371/journal.pone.0008261.g001
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um22 and aldh1a2
i26 mutant embryos, suggesting that
differentiation of the intestine takes place, although perhaps not
to completion. Expression of the early endoderm marker sox17 is
maintained (data not shown). Also, while our data suggest that
endocrine gene expression may be most sensitive to the loss of
Aldh1a2 function, we find that insulin (ins) expression remains in
some mutant embryos at 24, 48 and 72 hpf, suggesting that
endocrine gene expression is not completely blocked in the
mutants (Fig. 3C, D; Table 2). Lastly, we tested whether embryos
with residual expression of one endoderm gene had residual
expression of other endoderm genes, but did not observe a
correlation, suggesting that expression of each gene varies from
embryo to embryo (Figure S1).
The Aldh Inhibitor DEAB Completely Blocks Expression of
Endoderm Genes
We reasoned that the residual gene expression observed in
aldh1a2
um22 and aldh1a2
i26 mutant embryos could either
indicate that RA signaling is not completely required for
expression of all genes in the endoderm, or it might indicate
residual Aldh activity in the mutants. To test this further, we
made use of DEAB (diethylaminobenzaldehyde), a competitive
reversible inhibitor of all Aldh enzymes. DEAB has previously
been reported to block development of fin buds and otic
vesicles [29] and blocks expression of hoxb1b, vhnf1, krx20 in
rhombomere (r) 5, val in r5-6, hoxd4a and efnb2a in r7 of the
hindbrain [42]. Zebrafish embryos treated with DEAB have
been analyzed for a few endoderm markers [15,22,43,44,45].
In particular, insulin::GFP expression is lost in embryos treated
with DEAB [15,43,44,45]. Also, foxa3 expression in the
pancreas and liver and vhnf1 expression in the pancreas is lost
in DEAB treated embryos [45]. Loss of pharyngeal arches 3–5
was also seen when DEAB was used [46]. We find that treating
zebrafish embryos with 10 uM DEAB starting at 8 hpf (see
Figure S2 for DEAB titrations) blocks endoderm gene
expression. Specifically, expression of ins, pdx1, hhex, prox1,
sid4, carbA, ifabp and transf is completely lost in DEAB treated
e m b r y o s( F i g u r e3 B ,F ,J ,N ;F i g u r e4 B ,F ,J ,N ,R ;T a b l e2 )
while sox17 expression is unaffected (not shown). Notably,
treatment with lower concentrations (1–5 uM) of DEAB closely
mimics the phenotypes observed in aldh1a2
um22 and aldh1a2
i26
mutant embryos (Figure S2). We conclude that Aldh activity is
absolutely required for endoderm gene expression and that
there is residual Aldh activity in aldh1a2
um22 and aldh1a2
i26
mutant embryos.
Maternal aldh1a2 Activity Persists in aldh1a2
um22 and
aldh1a2
i26 Mutant Embryos
We next considered the likeliest source of residual Aldh activity
in aldh1a2
um22 and aldh1a2
i26 mutant embryos. The expression
patterns of aldh1a3 (raldh3; observed primarily in developing eye,
inner ear, pituitary gland and swim bladder) and aldh8a1 (raldh4;
found in liver and intestine, but not until day 2)[26,27] make them
unlikely candidates for providing Aldh activity in early pancreas
development. In addition, raldh1 is expressed in the dorsal retina
and mesencephalic flexure in mice [26], but has not been found in
zebrafish. Instead, we reasoned that there may be residual aldh1a2
activity in the mutants. Since the aldh1a2
um22 and aldh1a2
i26
mutations are likely to be null mutations, we considered the most
likely source of residual aldh1a2 activity to be maternally deposited
mRNA.
To test this possibility, we first carried out RT-PCR on 3 hpf
(before the onset of zygotic transcription) and 6 hpf (after the onset
of zygotic transcription) zebrafish embryos. We find that aldh1a2
mRNA is present already at 3 hpf (Figure 5A), consistent with a
role for maternal aldh1a2 mRNA. We reasoned that if the residual
aldh1a2 activity observed in the mutants is due to maternal mRNA,
then blocking aldh1a2 translation with antisense morpholino
oligonucleotides (aldh1a2 tMO) should produce the same pheno-
type as DEAB treatment. Indeed, we find that injecting aldh1a2
tMO, completely blocks expression of hhex (Figure 5C), prox1
(Figure 5E) and pdx1 (Figure 5G), producing a phenotype
indistinguishable from the DEAB phenotype and more severe
than the aldh1a2 mutant phenotype, while embryos injected with a
mismatch MO control show wild type expression of all endoderm
markers (Figure 5B, D, F). In contrast, we find that a MO
targeting the aldh1a2 exon 1/intron 1 splice junction (which should
not affect already spliced maternal aldh1a2 mRNAs) cannot fully
block endoderm gene expression even at the highest concentration
that could be tested (750 uM, not shown). We conclude that
aldh1a2 is the predominant aldh required for RA signaling during
endoderm development and that aldh1a2 has a significant maternal
component.
Figure 2. Wild type aldh1a2 mRNA rescues 88.21 fin bud
development. Dorsal views of 48 hpf embryos with sonic hedgehog
(shh) expression in purple. A. Uninjected wild type embryo with shh
expression in the CNS and fin buds (black arrows). B. aldh1a2
um22
mutant embryos lack shh expression in the fin buds. C. aldh1a2
um22
mutant embryo injected with aldh1a2 wild type mRNA shows rescued
fin bud expression (black arrows). D. aldh1a2
um22 mutant embryo
injected with aldh1a2
um22 mutant mRNA is not rescued.
doi:10.1371/journal.pone.0008261.g002
Table 1. Rescue 88.21 fin bud development.
Finbud No Finbud
Uninjected 113/153 (74%) 40/153 (26%)
Injected aldh1a2 mRNA 107/117 (91.5%) 10/117 (8.5%)
Injected 88.21/aldh1a2
um22 mRNA 61/80 (76%) 19/80 (24%)
Embryos from an incross of 88.21 heterozygotes were injected with 500 pg of
wild type aldh1a2 mRNA or aldh1a2 mRNA containing the 88.21 mutation.
Embryos were either fixed and assayed for fin bud expression by shh probe at
48 hpf or observed live at 72 hpf for fin bud development. Wild type aldh1a2
rescued fin bud development (91.5% of embryos have fin buds) whereas
aldh1a2 carrying the 88.21 mutation did not rescue (76% of embryos have fin
buds).
doi:10.1371/journal.pone.0008261.t001
A New Zebrafish aldh1a2 Mutant
PLoS ONE | www.plosone.org 5 December 2009 | Volume 4 | Issue 12 | e8261Discussion
We report results from an ENU (N-ethyl-N-nitrosourea) screen
for genes involved in endocrine pancreas development. We
characterize the aldh1a2
um22 allele, which corresponds to a glycine
to arginine mutation in the catalytic domain of the Aldh1a2
protein. aldh1a2
um22 mutant embryos show similarities to embryos
of two previously identified aldh1a2 mutants, neckless (nls or
aldh1a2
i26/i26) and no fin (nof, aldh1a2
u11/u11) [28,34] in that all
three mutants do not develop fin buds and have a swollen
pericardium. We compare the endoderm phenotype of aldh1a2
i26
and aldh1a2
um22 mutant embryos to that of embryos treated with
DEAB (a pan-Aldh inhibitor). Interestingly, endoderm markers are
not uniformly lost in aldh1a2 mutant embryos, but are lost in
DEAB-treated embryos, suggesting residual Aldh activity in the
mutants. We detect the presence of maternal aldh1a2 transcripts
and demonstrate that a morpholino targeting the aldh1a2
translation start site copies the DEAB phenotype. We conclude
that Aldh1a2 is the predominant Aldh enzyme acting in early
pancreas development and that there is a significant role for
maternally derived Aldh in this process.
Aldh Activity Is Required for Pancreas Development
Disrupted RA signaling has broad effects such as shorter body
length, curved body axis, lighter pigmentation, immobility, and a
swollen pericardium. As a result, many developmental defects are
observed, including neural crest cell death, the absence of limb
buds and posterior branchial arches, small somites, and hindbrain
segmentation defects, which have been known in general as VAD
(vitamin A-deficiency syndrome) [47,48,49]. In mouse, a null
mutation in the Aldh1a2 gene mimics the hindbrain phenotypes
associated with full VAD, establishing Aldh1a2 as the main RA
producing enzyme required in hindbrain development
[29,30,50,51]. As a result to losing RA, rhombomeric and gene
expression boundaries posterior to rhombomere (r) 3 are lost
[46,47,52,53,54,55,56]. In zebrafish embryos that are treated with
DEAB to block Aldh activity, defects in anterior-posterior
patterning of the neural tube also resemble severe VAD cases.
The neural tube is strongly anteriorized and hindbrain develop-
ment posterior to r4 is stopped. Also, loss of fin buds and reduction
of branchial arches are observed [28,34,57]. This indicates a
conserved role for Aldh enzymes in the production of RA required
for hindbrain development in both zebrafish and mice.
RA is also involved in endoderm development in vertebrates. In
mice, Aldh1a2 is expressed in the dorsal pancreatic mesenchyme
during pancreas specification and RA-responding cells reside in
both pancreatic endoderm and mesenchyme [58]. As a result,
defects in the endoderm are observed in the absence of RA. In
particular, Aldh1a2
2/2 mice lack Pdx1 and Prox1 expression in the
dorsal pancreatic bud but the ventral bud appears normal [2,58].
Accordingly, Insulin and Glucagon-expressing cells do not develop
and Isl1 expression is severely decreased [58]. Hlxb9, expressed in
the dorsal foregut endoderm, is also reduced [58]. Expression of
Foxa2 in the dorsoventral axis of the endoderm is not affected,
indicating that early endoderm development is unaltered [2]. Hhex
expression is not affected in the liver, suggesting that RA is not
involved in liver development – similar to observations in Xenopus
and avian embryos [2,12,13]. Treating Xenopus embryos with a RA
receptor antagonist (BMS493) blocks dorsal pancreatic develop-
ment, but does not affect ventral pancreatic development or the
liver [12]. Similarly, in RA-deficient avian embryos or VAD
(obtained from birds fed on a retinoid-deficient defined diet [59]),
dorsal pancreas is lost but not ventral pancreas or liver [7,48,59].
Since Xenopus embryos treated with BMS493, VAD quail embryos
and Aldh1a2
2/2 mutant mice display a similar phenotype - loss of
dorsal pancreas but not ventral pancreas or liver – it appears that
Table 2. DEAB, aldh1a2
um22, and aldh1a2
i26 in situ results.
Hpf1 Marker DEAB aldh1a2
um22 aldh1a2
i26
None
2 Weak
2 Wild type
2 None
2 Weak
2 Wild type
2 None
2 Weak
2 Wild type
2
24 ins 100% (99/99) 0% (0/0) 0% (0/0) 22% (37/167) 7% (12/167) 71% (118/167) 16% (13/79) 13% (10/79) 71% (56/79)
24 pdx1 100% (40/40) 0% (0/0) 0% (0/0) 0% (0/115) 24% (28/115) 76% (87/115) 15% (16/105) 9% (9/105) 76% (80/105)
30 hhex 100% (88/88) 0% (0/0) 0% (0/0) 14% (32/228) 12% (28/228) 74% (168/228) 12% (14/116) 15% (17/116) 73% (85/116)
30 isl1 100% (26/26) 0% (0/0) 0% (0/0) 25% (26/104) 0% (0/104) 75% (78/104) 26% (13/50) 0% (0/50) 74% (37/50)
30 p48 100% (27/27) 0% (0/0) 0% (0/0) 26% (32/125) 0% (0/125) 74% (93/125) 25% (16/64) 0% (0/64) 75% (48/64)
30 prox1 100% (93/93) 0% (0/0) 0% (0/0) 0% (0/63) 24% (15/63) 76% (48/63) 0% (0/195) 26% (50/195) 74% (145/195)
30 sst 100% (23/23) 0% (0/0) 0% (0/0) 24% (22/92) 0% (0/92) 76% (70/92) 26% (21/80) 0% (0/80) 74% (59/80)
48 ins 100% (25/25) 0% (0/0) 0% (0/0) 16% (10/63) 8% (5/63) 76% (48/63) 15% (12/78) 10% (8/78) 74% (58/78)
48 pdx1 100% (95/95) 0% (0/0) 0% (0/0) 0% (0/167) 25% (41/167) 75% (126/167) 12% (9/76) 12% (9/76) 76% (58/76)
48 shh 100% (24/24) 0% (0/0) 0% (0/0) 24% (13/54) 0% (0/54) 76% (41/54) 24% (15/62) 0% (0/62) 76% (47/62)
48 sid4 100% (87/87) 0% (0/0) 0% (0/0) 6% (12/189) 20% (38/189) 74% (139/189) 12% (18/146) 12% (18/146) 75% (110/146)
72 carbA 100% (33/33) 0% (0/0) 0% (0/0) 23% (57/245) 1% (2/245) 76% (186/245) 11% (13/117) 15% (18/117) 74% (86/117)
72 ifabp 100% (15/15) 0% (0/0) 0% (0/0) 0% (0/63) 24% (15/63) 76% (48/63) 0% (0/54) 22% (12/54) 78% (42/54)
72 ins 100% (25/25) 0% (0/0) 0% (0/0) 10% (5/52) 12% (6/52) 79% (41/52) 0% (0/25) 12% (3/25) 88% (22/25)
72 transf 100% (27/27) 0% (0/0) 0% (0/0) 0% (0/115) 24% (28/115) 77% (87/115) 2% (2/100) 21% (21/100) 77% (77/100)
1Hpf=hours post fertilization;
2Gene expression was classified into one of three categories: none, weak wild type.
Summary of gene expression data reported in figures 3 and 4. DEAB treated embryos, as well as embryos from incrosses of aldh1a2
um22 heterozygotes and aldh1a2
i26
heterozygotes were assayed by in situ hybridization and their expression classified into one of three categories (no expression, wild type expression and weak
expression). Embryos in each category are presented as a percent of the total number of embryos analyzed (actual numbers are given within parentheses).
doi:10.1371/journal.pone.0008261.t002
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necessary for dorsal pancreas development in these species. In
contrast, blocking RA completely in zebrafish embryos eliminates
all pancreas and liver gene expression. Embryos treated with
DEAB lose vhnf1 expression in the pancreas, insulin:GFP expression
in the endocrine pancreas, foxa3 expression in the pancreas and
liver, and pharyngeal arches 3–5 are lost as well [15,22,43,44,45].
We treated embryos with 10 uM DEAB at 8 hpf and found that
various endoderm markers expressed in the pancreas, liver, and
intestine are lost, similar to embryos treated with BMS493 (pan-
RAR antagonist) [15]. Also, injecting aldh1a2 translational MO
(tMO) knocks down insulin expression [8] and we find that aldh1a2
tMO knocks down expression of genes such as hhex (liver and
pancreas), prox1 (liver and pancreas), and pdx1 (pancreas and
duodenum) as well (Figure 5).
Thus, there appears to be a conserved role for RA in
pancreatic development among vertebrates, but mouse, Xenopus
and avian embryos have restricted RA’s role to the dorsal
pancreas. The liver and ventral pancreas emerge adjacent to
one another from the ventral endoderm in a default state as
pancreas, but the liver receives signals from the cardiac
mesoderm (FGF) to express liver markers [60]. Interestingly,
the markers that continue to be expressed in aldh1a2
um22 and
aldh1a2
i26 mutant zebrafish embryos are those expressed in the
ventral pancreas and liver (hhex, prox1, sid4, carbA,a n dtransf),
indicating that less RA is needed to turn on expression of these
genes, possibly consistent with an evolutionary phasing out of
RA’s involvement in these regions. Therefore, RA’s role in
ventral pancreas and liver development does not appear
evolutionarily conserved among vertebrates. Other signaling
factors may have taken precedence over RA in development of
these regions in mouse. For instance, BMP and FGF signaling is
necessary for liver development in mouse embryos, but
inhibiting FGF and BMP signaling in zebrafish embryos leads
t oad e c r e a s e ,n o tal o s s ,o fhhex and prox1 expression
[61,62,63,64].
Lastly, treatment with DEAB does not affect early endoderm
gene expression in zebrafish embryos (sox17) or mutant mouse
embryos (FoxA2) [2], indicating a conserved role that RA is not
necessary for early endoderm development in vertebrates.
The aldh1a2
i26, aldh1a2
u11 and aldh1a2
um22 Alleles Likely
Represent Null Mutations
The zebrafish aldh1a2 mutant alleles exhibit defects in
patterning of the neural tube and the endoderm, although the
phenotype is not as severe as in DEAB-treated zebrafish embryos
(Figs. 3, 4)[28,34], Aldh1a2
2/2 mutant mice or VAD quail and rat
embryos [28,34]. Instead, it is similar to the phenotype we observe
upon treatment with a low concentration of DEAB (Figure S2), as
well as to a mild version of VAD seen in rat embryos and to partial
rescue of Aldh1a2
2/2 mouse embryos by maternal application of
RA [51,55,65]. Since Aldh activity appears absolutely required for
pancreas formation (because DEAB-treated embryos lack endo-
derm gene expression, see above), the weaker phenotype of aldh1a2
Figure 3. aldh1a2
um22 and aldh1a2
i26 mutant embryos retain some endoderm gene expression at 24 and 30 hpf. DMSO treated wild
type embryos (A, E, I, M), DEAB-treated wild type embryos (B, F, J, N), embryos from an incross of aldh1a2
um22 heterozygotes (C, G, K, O) and embryos
from an incross of aldh1a2
i26 heterozygotes (D, H, L, P) were assayed for expression of ins at 24 hpf (A–D; black arrows indicate residual expression),
pdx1 at 24 hpf (E–H; black arrows indicate residual expression), hhex at 30 hpf (I–L; residual expression is indicated in pancreas (arrow) and liver
(arrowhead)) and prox1 at 30 hpf (M–P; residual expression is indicated in liver (arrowhead)). Embryos are in dorsal view with anterior to the left. See
Table 2 for quantification.
doi:10.1371/journal.pone.0008261.g003
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i26,
aldh1a2
u11 and aldh1a2
um22 alleles represent hypomorphic muta-
tions that maintain some residual Aldh activity.
However, the mutations occurring in the aldh1a2
i26, aldh1a2
u11
and aldh1a2
um22 alleles appear likely to be null mutations. In each
case, the mutated residue is conserved across human, mouse, rat,
Xenopus, and zebrafish [28,34], indicating that amino acid
sequence is important for the overall function of the Aldh1a2
protein and changing it will most likely affect the protein function.
Furthermore, in each case, the mutation introduces a large
charged residue (Gly -. Arg in aldh1a2
i26, Thr -. Lys in
aldh1a2
u11, Gly -. Arg in aldh1a2
um22). Such replacements are
likely to affect the proper folding of the protein and therefore affect
the catalytic function of Aldh1a2.
Further support for the idea that aldh1a2
i26, aldh1a2
um22 and
aldh1a2
u11 represent null mutations comes from rescue experi-
ments, which indicate that the mutant proteins are not functional.
When we injected aldh1a2
um22 embryos with mRNA containing the
aldh1a2
um22 mutation, it could not rescue fin bud development
(Figure 2 and Table 1). However, when we injected wild type
aldh1a2 mRNA, we were able to rescue fin bud development. The
same was seen in rescue experiments using both aldh1a2
i26 and
aldh1a2
u11 [28,34]. Furthermore, overexpression of the aldh1a2
um22
mutant mRNA in zebrafish embryos did not affect development
(not shown), further demonstrating that the aldh1a2
um22 allele is
inactive. Together, this indicates that the aldh1a2
i26, aldh1a2
um22
and aldh1a2
u11 mutations do not result in hypomorphic proteins,
but represent null mutations.
A Role for Maternal aldh1a2 mRNA
If the aldh1a2
i26, aldh1a2
u11 and aldh1a2
um22 alleles encode
inactive Aldh1a2, the fact that aldh1a2 mutant zebrafish embryos
do not display a severe VAD phenotype suggest that Aldh activity
must be coming from another source. The expression pattern of
other aldhs rules them out as likely candidates and we therefore
focused on maternal aldh1a2 mRNA. We find that aldh1a2 is
expressed already at 3 hpf, albeit at somewhat lower levels – this
lower level may explain the weak phenotype observed in the
mutants. We also find that a MO targeting the exon 1/intron 1
splice site of aldh1a2 (sMO, which should target only zygotic
transcripts) produces a milder phenotype (not shown) and that
lower doses of aldh1a2 tMO (500 uM) permit some expression of
Figure 4. aldh1a2
um22 and aldh1a2
i26 mutant embryos retain some endoderm gene expression at 48 and 72 hpf. DMSO treated wild
type embryos (A, E, I, M, Q), DEAB-treated wild type embryos (B, F, J, N, R), embryos from an incross of aldh1a2
um22 heterozygotes (C, G, K, O, S) and
embryos from an incross of aldh1a2
i26 heterozygotes (D, H, L, P, T) were assayed for expression of pdx1 at 48 hpf (A–D), sid4 at 48 hpf (E–H), carbA at
72 hpf (I–L), ifabp at 72 hpf (M–P) and transf at 72 hpf (Q–T). Gene expression is observed in the intestine (open arrows), liver (black arrowheads) and
pancreas (black arrows). Embryos are in dorsal view with anterior to the left. See Table 2 for quantification.
doi:10.1371/journal.pone.0008261.g004
A New Zebrafish aldh1a2 Mutant
PLoS ONE | www.plosone.org 8 December 2009 | Volume 4 | Issue 12 | e8261pdx1, similar to the phenotype observed in aldh1a2
um22 and
aldh1a2
i26 mutant embryos). We also note that after treating with
DEAB, it became clear that aldh1a2
i26 embryos still have some RA
activity since DEAB treated embryos display a severe phenotype
similar to VAD [34,57,65]. This residual aldh1a2 is most likely due
to maternally supplied mRNA.
In contrast, Aldh enzymes do not appear to be deposited
maternally in other vertebrates. In particular, the fact that aldh1a2
mutations in mice mimic the VAD phenotype [47,48,49], suggests
that there are no maternally contributed Aldhs in the mouse. In
Xenopus, both retinol and retinaldehyde are present in embryos
before gastrulation, indicating that RDHs may be present (possibly
maternally deposited) [57,66]. Furthermore, microinjection of
Aldh1 or Aldh1a induces premature RA signaling in Xenopus [67] by
acting on this retinaldehyde pool, suggesting that maternally
deposited Aldhs are not present in the Xenopus embryo
[28,50,67,68]. It is not clear why aldh1a2 is maternally deposited
in zebrafish, but our observation that treatment with DEAB before
gastrulation results in death or severely deformed embryos (not
shown) suggests that there may be an early role for aldh1a2 in
zebrafish embryos.
Supporting Information
Figure S1 Double in situ in aldh1a2
um22 and aldh1a2
i26 mutant
embryos. Wild type (A, F), aldh1a2
um22 (B, C, G, H) and aldh1a2
i26
(D, E, I, J) embryos were assayed for expression of prox1/ins at
30 hpf (A-E) and carbA/ins at 72 hpf (F-J). Ins expression is detected
in purple, while prox1 (A-E) and carbA (F-J) are detected in red. We
do not observe any correlation in the extent of residual expression
by these genes in individual embryos.
Found at: doi:10.1371/journal.pone.0008261.s001 (3.80 MB TIF)
Figure S2 Titration of DEAB and aldh1a tMO. Wild type (A),
aldh1a2
um22 mutant (B), aldh1a2
i26 mutant (C), DEAB-treated
(D-G) and aldh1a2 tMO-injected (H-K) embryos were assayed
for pdx1 expression at 48 hpf. DEAB and aldh1a2 tMO was
titrated as indicated (D-G and H-K, respectively). Black arrows
indicate pancreas expression and open arrows indicate duode-
num expression of pdx1. Note that intermediate concentrations
of DEAB (1 uM, panel E) and aldh1a2 tMO (250–500 uM,
panels I, J) produce similar phenotypes to the aldh1a2
um22 and
aldh1a2
i26 mutants. Embryos are in dorsal view with anterior to
the left.
Found at: doi:10.1371/journal.pone.0008261.s002 (6.16 MB TIF)
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